Hemianopsia Rehabilitation After Stroke or Brain Injury

NCT06241209 · tracked via the Priya Life Science Canada tracker

Sponsor

University of Alberta

Phase

Not applicable

Started

2024-01-25

Last updated

2026-03-16

Condition(s) studied

HemianopsiaVisual Field Defect, PeripheralVisual Impairment

Investigational drug(s) / intervention(s)

PowerPoint program visual stimulation

PowerPoint program visual stimulation: Moving objects, food, money, and other targets will be presented in the remaining seeing, and hemianopic areas.

Study summary

In patients with hemianopsia following stroke or brain injury, we will determine if stimulating the visual field with images from a PowerPoint slide set can increase the visual field.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: All patients 18 years of age or older with a homonymous hemianopsia or quadrantopsia, who can provide informed consent, and communicate in English. Exclusion Criteria: * The flashing lights from thge automated perimeter and PowerPoint program can potentially trigger photic seizures. Therefore patients with light-induced seizures are excluded.

Primary outcome measure(s)

Visual Field Index on Humphrey perimetry — 2 months
(100 is an intact field)

Trial sites (1)

Facility	City	Region	Status
Eye Institute of Alberta, Royal Alexandra Hospital	Edmonton	Alberta	Recruiting

More University of Alberta trials in Canada

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants Recruiting

Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study Recruiting

Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD Active, not recruiting

Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy Recruiting

Multidisciplinary Support To Access Living Donor Kidney Transplant-Pilot Active, not recruiting

Other trials for the same condition

Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour Starting soon

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema Active, not recruiting

Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06241209 on ClinicalTrials.gov ↗ ← All trials in Canada